Skip to main content
. 2019 Mar 27;7:e6539. doi: 10.7717/peerj.6539

Table 1. Univariate and multivariate analyses of overall survival (OS) in the eligible patients.

Variables N (%) Univariate analysis Multivariate analysis
P-value HR [95%CI] P-value
Age <0.001 <0.001
 <60 425 (27.8%) Reference
 ≥60 and <80 963 (62.9%) 1.203 [1.053–1.375] 0.007
 ≥80 142 (9.3%) 1.530 [1.238–1.891] <0.001
Sex 0.001 0.004
 Male 855 (55.9%) Reference
 Female 675 (44.1%) 0.845 [0.754–0.947]
Race 0.885 NI
 White 1283 (83.9%)
 Black 187 (12.2%)
 Other# 60 (3.9%)
Marital status 0.276 NI
 Married 839 (54.8%)
 Unmarried 691 (45.2%)
Laterality 0.289 NI
 Bilateral 4 (0.4%)
 Left 623 (40.3%)
 Right 903 (59.3%)
Primary site <0.001 0.443
 Main bronchus 64 (4.2%) Reference
 Upper lobe 948 (62.0%) 0.917 [0.700–1.202] 0.531
 Middle lobe 82 (5.4%) 1.118 [0.793–1.577] 0.524
 Lower lobe 408 (26.7%) 0.891 [0.673–1.181] 0.423
 Overlapping lesion 28 (1.8%) 0,836 [0.507–1.377] 0.482
Differentiation <0.001 0.322
 Grade III 586 (38.3%) Reference
 Grade IV 191 (12.5%) 1.157 [0.957–1.399] 0.133
 Unknown 753 (49.2%) 1.035 [0.909–1.179] 0.603
AJCC stage groups 8th edition <0.001 <0.001
 I 395 (25.8%) Reference
 II 133 (8.7%) 2.619 [2.027–3.384] <0.001
 III 305 (19.9%) 2.606 [2.083–3.260] <0.001
 IV 697 (45.6%) 4.881 [3.923–6.072] <0.001
Surgery <0.001 <0.001
 No surgery 908 (59.3%) Reference
 Segmentectomy/wedge resection 133 (8.7%) 0.526 [0.413–0.669] <0.001
 Lobectomy/Bilobectomy 425 (27.8%) 0.357 [0.290–0.440] <0.001
 Pneumonectomy 64 (4.2%) 0.491 [0.355–0.679] <0.001
Chemotheray 0.264 <0.001
 No/unknown 742 (48.5%) Reference
 Yes 788 (51.5%) 0.442 [0.389–0.503]
Radiation <0.001 0.005
 No/unknown 965 (63.1%) Reference
 Yes 565 (36.9%) 0.837 [0.738–0.949]

Notes:

N, number; HR, hazard ratio; 95% CI, 95% confidence index; NI, not included in the multivariate survival analysis.

#

Other: American Indian/AK Native, Asian/Pacific Islander.